skip to Main Content

Non-regulatory Press releases

Första dag för handel med teckningsoptioner, PILA TO 1, blir den 22 juli 2021

Malmö, 20 juli, 2021 Läs pressmeddelandet som PDF här PILA PHARMA AB meddelar att handeln med teckningsoptioner TO 1, under kortnamnet ”PILA TO 1” med ISIN-kod SE0016274005, börjar handlas den 22 juli 2021. Som tidigare kommunicerats har PILA PHARMA AB (publ) (”PILA PHARMA” eller ”Bolaget”) genomfört en fulltecknad unit-emission av aktier och teckningsoptioner av serie TO 1 (”Teckningsoptionerna”) som tillförde…

read more

I DAG, DEN 15 JULI 2021, ÄR FÖRSTA HANDELSDAG FÖR PILA PHARMA PÅ NASDAQ FIRST NORTH GROWTH MARKET

Malmö, 15 juli, 2021 Läs pressmeddelandet som PDF här PILA PHARMA AB meddelar att i dag, den 15 juli 2021, inleds handeln med PILA PHARMA AB:s ("PILA PHARMA" eller "Bolaget") aktie på Nasdaq First North Growth Market. PILA PHARMA:s aktie handlas under kortnamnet "PILA" med ISIN-kod SE0015988274. Teckningsoptionen handlas under kortnamnet "PILA TO 1" med ISIN-kod SE0016274005, och börjar handlas…

read more

PILA PHARMA AB, a Swedish biotech company, announces adjustment to the management team to prepare for coming upscaling of the company.

Malmö, Sweden, May 21, 2021 Download the press release as PDF here “I am pleased to share the information that we have promoted Lars Bukhave Rasmussen, to become Chief Operating Officer (COO).  Further, I’m proud to announce the appointment of Elna Lembrér Åström, to new Chief Financial Officer (CFO)”, says CEO Dorte X. Gram.  Lars Bukhave Rasmussen joined PILA PHARMA in…

read more

PILA PHARMA announces successful completion of Pre-IPO

Malmö, Sweden, 10 March 2021 Download the press release as PDF here PILA PHARMA AB, a Swedish biotech company, today, announces the successful completion of a recent new shares issue (Pre-IPO).  “I am very happy to share the information that we have successfully raised the 15 MSEK that we set out to do and previously communicated we would”, says CEO…

read more

PILA PHARMA announces plans for an IPO in Q2-2021

Malmö, Sweden, 17h November 2020 Download the press release as PDF here PILA PHARMA AB, a Swedish biotech company, is pleased to announce the decision to list the company. The Initial Public Offering (IPO), aiming for listing of the company’s shares on one of the unregulated stock exchanges in Sweden, is targeted for Q2-2021.To facilitate the IPO process, Göteborg Corporate…

read more

Contact us

Back To Top
Search